<DOC>
	<DOCNO>NCT00266721</DOCNO>
	<brief_summary>The hypothesis study administration pancrelipase meal benefit symptoms post-prandial bloating , pain eructation .</brief_summary>
	<brief_title>Efficacy Pancrelipase Postprandial Belching Bloating .</brief_title>
	<detailed_description>Subjects complete double-blind crossover study , one week period , receive two pancrelipase tablet three major meal similarly administer identical placebo . Three time daily , subject rate severity belching , epigastric discomfort , epigastric fullness , bloating , nausea .</detailed_description>
	<mesh_term>Eructation</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Subjects either bothersome upper abdominal discomfort , bloat ( feel abdominal distention ) belching follow meal least 12 month 's duration . Subjects must normal upper gastrointestinal endoscopy and/or upper GI series precede three year . Individuals history suggestive organic disease recent weight loss , nausea , vomit , GERD , recent change bowel habit exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2000</verification_date>
	<keyword>Pancrelipase</keyword>
	<keyword>Abdominal bloating</keyword>
	<keyword>Abdominal pain</keyword>
	<keyword>Eructation</keyword>
</DOC>